Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2004
10/06/2004EP0970070B1 Phthalazines with angiogenesis inhibiting activity
10/06/2004CN1535270A Tetrahydropyridazine derivatives and their use as pesticides
10/06/2004CN1535267A 5-membered heterocycles, preparation and use thereof as medicine
10/06/2004CN1535266A Dihydro-benzo [b][1,4] diazepin-2-one derivatives as mglur 2 antagonists II
10/06/2004CN1169798C Novel diazo alcoholic antifungal compound and its preparing process
10/06/2004CN1169797C Antiviral phrimidinedione derivatives and process for preparation thereof
10/06/2004CN1169795C Cycloamine substituted nitrogenous heterocyclic compounds and its composition
10/06/2004CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases
10/05/2004US6800762 Indolin derivaties as sun protection agents
10/05/2004US6800761 Form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
10/05/2004US6800760 Inhibitors of vascular endothelial growth factor receptor tyrosine kinase
10/05/2004US6800676 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith
10/05/2004US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004US6800645 Substituted azabicyclic compounds
10/05/2004US6800644 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds
10/05/2004US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells
10/05/2004CA2282834C Novel hexanoic acid derivatives
09/2004
09/30/2004WO2004083203A1 Compositions useful as protein kinase inhibitors
09/30/2004WO2004083202A1 A process for the preparation of indolymaleimides
09/30/2004WO2004083187A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
09/30/2004WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
09/30/2004WO2004083173A2 Ketopiperazine derivatives as bradykinin antagonists
09/30/2004WO2004082687A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
09/30/2004WO2004082678A1 Aryl spirohydantoin cgrp receptor antagonists
09/30/2004WO2004082621A2 Novel ppar agonists, pharmaceutical compositions and uses thereof
09/30/2004WO2004082616A2 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity
09/30/2004WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists
09/30/2004WO2004062568A3 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
09/30/2004WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity
09/30/2004WO2004041209A3 Transcription factor modulating compounds and methods of use thereof
09/30/2004WO2004037786A3 2-pyrrolidones as ep4 receptor agonists
09/30/2004US20040192930 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis
09/30/2004US20040192927 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof
09/30/2004US20040192914 Compounds and methods
09/30/2004US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation
09/30/2004US20040192752 Anti-HIV pyrazole derivatives
09/30/2004US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease
09/30/2004US20040192749 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
09/30/2004US20040192748 Heterocyclic compounds
09/30/2004US20040192743 Substituted azole derivatives as therapeutic agents
09/30/2004US20040192735 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
09/30/2004US20040192713 Novel synthesis of irbesartan
09/30/2004US20040192695 Reacting phthalidyl-3-triphenylphosphonium salt with 4-pyridine aldehyde in the presence of a basic adjuvant, then reacting with hydrazine hydrate and acid treatment; avoids environmental and safety problems
09/30/2004US20040192693 Antidiabetic agents; arteriosclerosis; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents
09/30/2004US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain
09/30/2004US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
09/30/2004US20040192671 Benzo[d]azepine derivatives as 5-ht6 receptor anatagonists
09/30/2004US20040192668 3-(imidazolyl)-2-aminopropanoic acids
09/30/2004US20040192667 Novel pyrazole analogs acting on cannabinoid receptors
09/30/2004US20040192666 Nonnucleoside reverse transcriptase inhibitors
09/30/2004US20040192653 P38 inhibitors and methods of use thereof
09/30/2004US20040191210 Compounds
09/30/2004CA2522176A1 Compositions useful as protein kinase inhibitors
09/30/2004CA2519297A1 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity
09/30/2004CA2518852A1 Monocyclic anilide spirohydantoin cgrp receptor antagonists
09/30/2004CA2518843A1 Aryl spirohydantoin cgrp receptor antagonists
09/30/2004CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists
09/29/2004EP1462453A1 Paraphenylenediamin derivatives comprising a substituted pyrrolidinyl group and bearing a cationic radical as well as their use for dyeing keratinic fibres
09/29/2004EP1462445A1 Paraphenyldiamine derivatives concisting of a cyclic diaza group substituted by a cationic radical and use of these derivatives for dyeing keratin fibres
09/29/2004EP1461334A2 Pyrazole derived kinase inhibitors
09/29/2004EP1461321A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
09/29/2004EP1461083A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
09/29/2004EP1461035A2 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
09/29/2004EP1461026A2 Method for treating ocular hypertension
09/29/2004EP1460996A2 Novel-n-4-(1h-imidazol-1-yl)-2-fluorophenyl]-3-(trifluoromethyl)-1-h-pyrazole-5-carboxamides as factor xa
09/29/2004EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
09/29/2004EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases
09/29/2004EP1003821B1 Anisotropic retardation layers for display devices
09/29/2004EP0901487B9 2,3,6 trisubstituted-4(3h)-quinazolinones
09/29/2004EP0805804B1 Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides
09/29/2004CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
09/29/2004CN1533286A Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
09/29/2004CN1532195A Novel method for preparing olmesartan
09/29/2004CN1168721C 5-cyano-2-aminopyrimidine derivatives
09/29/2004CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them
09/29/2004CN1168714C Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers
09/29/2004CN1168704C Aryl and heteroaryl cyclopropyl oximidoether and its application as bactericide and pesticide
09/28/2004US6797825 Protein kinase inhibitors
09/28/2004US6797824 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
09/28/2004US6797823 Quinoline derivatives and quinazoline derivatives
09/28/2004US6797820 Succinate compounds, compositions and methods of use and preparation
09/28/2004US6797725 Prodrugs of a 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
09/28/2004US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties
09/28/2004US6797709 Sexual disorders
09/28/2004US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents
09/23/2004WO2004081006A1 Weak base salts
09/23/2004WO2004081005A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
09/23/2004WO2004081002A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
09/23/2004WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation
09/23/2004WO2004080981A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
09/23/2004WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
09/23/2004WO2004080977A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors
09/23/2004WO2004080976A1 Phthalazinone derivatives
09/23/2004WO2004080973A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors
09/23/2004WO2004080972A1 Pirazole modulators of atp-binding cassette transporters
09/23/2004WO2004080970A1 Novel bicyclic aromatic compounds, the production and use thereof in the form of drugs
09/23/2004WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
09/23/2004WO2004080480A1 Pharmaceutical preparations comprising acid-stabilised insulin
09/23/2004WO2004080390A2 Antiprotozoal imidazopyridine compounds
09/23/2004WO2004056785A3 Uracils having a herbicidal activity